Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
82.52
+4.22 (5.39%)
At close: Jun 9, 2026, 4:00 PM EDT
82.52
0.00 (0.00%)
Pre-market: Jun 10, 2026, 7:37 AM EDT
Globus Medical Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Globus Medical stock has a consensus rating of "Buy" and an average price target of $110. The average 1-year stock price forecast is 33.30% higher than the current stock price, while the lowest is $87 (+5.43%) and the highest is $122 (+47.84%).
Price Target: $110 (+33.30%)
Analyst Consensus: Buy
* Price targets were last updated on May 11, 2026.
Analyst Ratings
The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 5 | 6 |
| Buy | 4 | 5 | 5 | 4 | 4 | 4 |
| Hold | 5 | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 14 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $123 | Buy | Maintains | $123 | +49.05% | May 11, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $112 → $115 | Buy | Maintains | $112 → $115 | +39.36% | May 8, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 8, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $115 | Buy | Maintains | $115 | +39.36% | May 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $115 → $120 | Buy | Maintains | $115 → $120 | +45.42% | May 8, 2026 |
Financial Forecast
Revenue This Year
3.20B
from 2.94B
Increased by 8.99%
Revenue Next Year
3.41B
from 3.20B
Increased by 6.41%
EPS This Year
4.74
from 3.98
Increased by 19.19%
EPS Next Year
5.15
from 4.74
Increased by 8.59%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 3.2B | ||
| Avg | 3.2B | ||
| Low | 3.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 9.6% | ||
| Avg | 9.0% | ||
| Low | 8.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 4.74 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 19.2% | ||
| Low | - |